Valneva SE (INRLF, $2.3) was a top loser over the last three months, falling -2 to $2.3 per share. A.I.dvisor analyzed 849 stocks in the Biotechnology Industry for the 3-month period ending January 22, 2025, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.